Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq

Michael Heltzen appointed as CEO bringing 20 years of global commercial leadership experience and a track record of successful launches and exitsAdditional industry veterans join in key roles including business development, finance, and communications MONROVIA, Calif., May 07, 2024 (GLOBE NEWSWIRE) --  Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday life, today announced the appointment ...